| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 28.701 | 1.470 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 28.701 | 1.470 | - | 0 | 0 | 0 | 0 | 87 | 0 | 0 |
| Total Expenses - EUR | 30.094 | 3.891 | - | 0 | 0 | 0 | 2.772 | 7.483 | 434 | 287 |
| Gross Profit/Loss - EUR | -1.392 | -2.421 | - | 0 | 0 | 0 | -2.772 | -7.395 | -434 | -287 |
| Net Profit/Loss - EUR | -2.336 | -2.431 | - | 0 | 0 | 0 | -2.772 | -7.398 | -434 | -287 |
| Employees | 2 | 0 | - | 0 | 0 | 0 | 1 | 2 | 0 | 0 |
Check the financial reports for the company - Bayer Invest Anms S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 16.986 | 13.339 | - | 1.963 | 1.925 | 1.889 | 1.330 | 2.630 | 4.115 | 3.956 |
| Inventories | 240 | 238 | - | 230 | 225 | 221 | 216 | 217 | 216 | 215 |
| Receivables | 7.037 | 6.785 | - | 1.906 | 1.869 | 1.834 | 1.328 | 2.560 | 3.813 | 3.791 |
| Cash | 9.709 | 6.316 | - | -173 | -169 | -166 | -214 | -147 | 87 | -50 |
| Shareholders Funds | -1.639 | -4.053 | - | -3.989 | -3.911 | -3.837 | -6.525 | -13.943 | -14.335 | -14.542 |
| Social Capital | 45 | 45 | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 18.625 | 17.392 | - | 5.952 | 5.837 | 5.726 | 7.855 | 16.573 | 21.493 | 21.524 |
| Income in Advance | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4120 - 4120" | |||||||||
| CAEN Financial Year |
4120
|
|||||||||
Comments - Bayer Invest Anms S.r.l.